Report Highlights
The global market for bariatric devices should increase from $1.5 billion in 2020 to nearly $2.2 billion by 2025 at a compound annual growth rate (CAGR) of 7.5% during the forecast period, 2020-2025.
Report Includes
- 44 data tables and 22 additional tables
- An overview of the global market for services and devices for bariatric surgery
- Estimation of the market size and analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of market size and forecast, technological advancements within the industry and market share analysis of services and devices of bariatric surgery based on procedure type, device type, end user, and region
- An introduction to obesity, common tools to diagnose obesity including BMI, waist circumference, and skinfold thickness, and discussion on risk factors related to obesity such as type 2 diabetes
- Discussion on economic burden and epidemiology of obesity and detailed description of diabetes including symptoms and risk factors, epidemiology and medication and insulin therapy
- Description of bariatric surgery procedures including laparoscopic, endoscopic, and open surgery and discussion on benefits, limitations and complications of bariatric surgeries, and information on bariatric surgery devices such as assisting, suturing and stapling devices
- Coverage of key marketed, pipeline and abandoned products within bariatric devices technologies; and insight into the reimbursement scenario and international classification of diseases and codes for key bariatric procedures
- Global company share analysis of the leading companies dealing in bariatric assisting devices and bariatric implantable devices
- Company profiles of major industry players, including Apollo Endosurgery Inc., Boston Scientific Corp., Cook Medical LLC, Ethicon Endo-Surgery (a subsidiary of Johnson & Johnson), Medtronic Plc and ReShape Lifesciences
Report Scope
This report aims to provide a comprehensive study of the global market for bariatric surgery, including services and devices. It provides a detailed description of the different types of bariatric procedures (invasive and noninvasive) and relevant devices.
Bariatric procedures include sleeve gastrectomy, gastric bypass, gastric banding, one anastomosis gastric bypass and others. Bariatric devices are segmented into assisting and implantable devices. This report also covers a detailed study of conditions, obesity and diabetes, which are the major reasons for the uptake of bariatric procedures, worldwide.
An in-depth analysis of the global market for bariatric surgery and devices includes historical data and market projection on sales by procedure type, device type, end-user and region. The regulatory aspects concerning the bariatric surgery market include marketed and pipeline (R&D) products along with description, regulatory status and clinical trials and reimbursement.
For in-depth understanding of the market, profiles of market participants and associations, competitive landscape, key competitors and respective market shares have been provided in this report. This report also discusses driving and restraining factors of the global bariatric surgery and device market and trends and opportunities in the market.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
Report Highlights
The global market for bariatric surgery devices was worth more than $1.2 billion in 2014. The market reached $1.4 billion in 2015 and a projected $2.2 billion by 2020, increasing at a compound annual growth rate (CAGR) of 9.8% from 2015 through 2020.
Report Includes
- An overview of the global market for services and devices used in the bariatric surgery sector.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Discussion on types of obesity, etiology and pathophysiology, risk factors, economic burden, epidemiology, and obesity treatment and management.
- An examination of the types and the criteria for bariatric surgeries, along with common complications and the average cost associated with post-surgical complications.
- A historical perspective on and the current scenario for bariatric surgery procedure.
- An evaluation of the current clinical challenges, unmet needs, and future outlook.
- Profiles of major players in the industry.
Report Highlights
The global market for bariatric surgery devices was worth nearly $1.1 billion in 2012. The market is expected to reach nearly $1.2 billion in 2013 and almost $1.9 billion by 2018, with a compound annual growth rate (CAGR) of 9.6% between 2013 and 2018.
Report Includes
- An overview of the global market for services and devices in the bariatric surgery sector.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 and 2018.
- Discussion on types of obesity, etiology and pathophysiology, risk factors, economic burden, epidemiology, and obesity treatment and management.
- An examination of the types and the criteria for bariatric surgeries, along with common complications and the average cost associated with post-surgical complications.
- A historical perspective on and the current scenario for bariatric surgery procedure.
- An evaluation of the current clinical challenges, unmet needs, and future outlook.
Related Reports
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
mRNA: Therapeutics and Global Markets
The global market for mRNA therapeutics is expected to decline from $33 billion in 2023 to $21 billion by the end of 2028, at a compound annual growth rate (CAGR) of -8.6% during the forecast period of 2023-2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More